One of the first catheter treatments for congenital heart lesions, balloon pulmonary valvuloplasty is now the recognized standard therapy for pulmonary valve stenosis in children. While earlier studies focused on technique, safety, and efficacy, more recent work has been aimed at evaluating intermediate and long term results after balloon dilation procedures. From the earliest application of balloon pulmonary valvuloplasty, investigators explored the use of the technique for treatment of the newborn with critical valvar stenosis. Improvements in catheters and technique have led to wider application of dilation for newborn critical pulmonic stenosis. Thus considerably more information is available regarding this small but important subset of patients. Recently, modified techniques have been developed for treatment of newborns with pulmonary atresia, and valvuloplasty has been used as palliative therapy for cyanotic disease, particularly tetralogy of Fallot.This discussion will focus on recent information regarding balloon dilation of the pulmonary valve. We will review newer data regarding followup of patients after dilation of simple valvar stenosis and discuss the experience in newborns in more detail. Attention will then be turned to the currently controversial role of valvuloplasty in pulmonary atresia and tetralogy of Fallot.
Simple Pulmonary Valve StenosisThe technique for dilation of pulmonary valve stenosis has changed little since early reports [15,22,28]. Several series have confirmed the important relationship between balloon to annulus ratio and gradient reduction. Oversized balloons are clearly required to achieve optimal results [23]. Technological advancement resulting in low profile construction of valvuloplasty catheters has largely removed concern about vascular injury in patients of all ages. Immediate and short-term results after valvuloplasty are excellent in the vast majority of children with isolated valvar stenosis. Patients with so called dysplastic pulmonary valve, many of whom carry the diagnosis of Noonan's syndrome, are the one group of patients in whom inadequate gradient relief is a significant problem after balloon valve dilation [28]. Outcome of the procedure is not related to the diagnosis of Noonan's syndrome per se but rather is dependent on valve morphology. No studies have successfully demonstrated specific anatomic predictors of success (or failure) in valvuloplasty of the dysplastic valve. Our experience would suggest that patients least likely to benefit are those in whom significant annular hypoplasia and supravalvar narrowings are present (Figure 1).Long term outcome after treatment of pulmonary valve stenosis is dependent on (1) pressure loading of the right ventricle from residual or recurrent obstruction, and (2) volume loading as a result of pulmonary insufficiency. A number of centers have reported intermediateterm followup after balloon pulmonary valvuloplasty, but long-term data are still limited. The largest study to date reports follow-up obtained for 533 patient...